- Home
- DCTH vs EHAB Comparison
DCTH vs EHAB Comparison
Compare DCTH & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- EHAB
- Stock Information
- Founded
- DCTH 1988
- EHAB 2014
- Country
- DCTH United States
- EHAB United States
- Employees
- DCTH N/A
- EHAB N/A
- Industry
- DCTH Medical/Dental Instruments
- EHAB Hospital/Nursing Management
- Sector
- DCTH Health Care
- EHAB Health Care
- Exchange
- DCTH Nasdaq
- EHAB Nasdaq
- Market Cap
- DCTH 388.3M
- EHAB 409.1M
- IPO Year
- DCTH N/A
- EHAB N/A
- Fundamental
- Price
- DCTH $11.75
- EHAB $8.06
- Analyst Decision
- DCTH Strong Buy
- EHAB Buy
- Analyst Count
- DCTH 4
- EHAB 3
- Target Price
- DCTH $24.50
- EHAB $8.67
- AVG Volume (30 Days)
- DCTH 497.8K
- EHAB 360.2K
- Earning Date
- DCTH 11-07-2025
- EHAB 11-05-2025
- Dividend Yield
- DCTH N/A
- EHAB N/A
- EPS Growth
- DCTH N/A
- EHAB N/A
- EPS
- DCTH 0.06
- EHAB N/A
- Revenue
- DCTH $70,240,000.00
- EHAB $1,037,800,000.00
- Revenue This Year
- DCTH $159.22
- EHAB $4.95
- Revenue Next Year
- DCTH $42.78
- EHAB $4.33
- P/E Ratio
- DCTH $211.26
- EHAB N/A
- Revenue Growth
- DCTH 491.35
- EHAB N/A
- 52 Week Low
- DCTH $8.08
- EHAB $6.47
- 52 Week High
- DCTH $18.23
- EHAB $10.91
- Technical
- Relative Strength Index (RSI)
- DCTH 59.13
- EHAB 57.15
- Support Level
- DCTH $10.61
- EHAB $7.53
- Resistance Level
- DCTH $11.38
- EHAB $8.16
- Average True Range (ATR)
- DCTH 0.49
- EHAB 0.25
- MACD
- DCTH 0.06
- EHAB -0.02
- Stochastic Oscillator
- DCTH 79.61
- EHAB 84.13
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.